Skip to main content
. 2022 Jul 1;6(13):3861–3869. doi: 10.1182/bloodadvances.2021005684

Table 4.

Patients with MDS or AML diagnosed before 1 January 2000 or on and after 1 January 2000

Before 01/01/2000 After 01/01/2000 Total
Patients with MDS/AML 29 48 77
Patients with chemotherapy only, n (%) 10 (34) 8 (20) 18 (23)
 Living 0 0 0
 Deceased 9 (90) 8 (100) 17 (90)
 Lost to follow-up 1 (10) 0 1
Patients with chemotherapy and HSCT, n (%) 19 (66) 40 (83) 59 (77)
 Living 5 (26) 18 (45) 23 (39)
 Deceased 14 (74) 22 (55) 36 (61)
 Lost to follow-up 0 0 0